Futura licenses erectile dysfunction drug to Quantum Pharma
Wednesday, October 14, 2015
Futura Medical Plc has out-licensed exclusive rights to Quantum Pharma for manufacture and supply of med2002 as an unlicensed medicine ("special") in UK.
Signed an agreement under which med2002, Futura's novel treatment for erectile dysfunction, will soon be available as an unlicensed medicine.
In return, Futura will receive undisclosed royalty payments from Quantum on sales of product .
reuters.com
